CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary

Neurochemical Research

Volumn 30, Issue 8, 2005, Pages 943-948

  Juhász, Anna ^a   Rimanóczy, Ágnes ^a   Boda, Krisztina ^a   Vincze, Gábor ^b   Szlávik, Gyozo ^b   Zana, Marianna ^a   Bjelik, Annamária ^a   Pákáski, Magdolna ^a   Bódi, Nikoletta ^a   Palotás, András ^a,c   Janka, Zoltán ^a   Kálmán, János ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Pandy Kalman Bekes County Hospital   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; ApoE; CYP46; Gene polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN E; OXYGENASE; STEROID 24 HYDROXYLASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUNGARY; INTRON; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; ONSET AGE; PLASMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; GENETICS, POPULATION; HUMANS; HUNGARY; MALE; POLYMORPHISM, GENETIC; STEROID HYDROXYLASES;

EID: 27644511599     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-005-5979-4     Document Type: Article

References (35)

1. A. R. Koudinov T. T. Berezov N. V. Koudinova 2001 The levels of soluble Aβ in different HDL subfractions distinguish Alzheimer's and normal aging CSF: implication for brain cholesterol pathology? Neurosci. Lett. 314 115 118
2. I. Bjorkhem D. Lutjohann O. Breuer A. Sakinis A. Wennmalm 1997 Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro J. Biol. Chem. 272 30178 30184
3. I. Bjorkhem D. Lutjohann U. Diczfalusy L. Stahle G. Ahlborg J. Wahren 1998 Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation J. Lipid Res. 39 1594 1600
4. D. Lutjohann K. von Bergmann 2003 24S-hydroxycholesterol: A marker of brain cholesterol metabolism Pharmacopsychiatry 36 2 S102 106
5. L. Bretillon D. Lutjohann L. Stahle T. Widhe L. Bindl G. Eggertsen U. Diczfalusy I. Bjorkhem 2000 Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J. Lipid Res. 41 840 845
6. J. Li-Hawkins E. G. Lund A. D. Bronson D. W. Russell 2000 Expression cloning of an oxysterol 7α-hydroxylase selective for 24-hydroxycholesterol J. Biol. Chem. 275 16543 16549
7. N. Bogdanovic L. Bretillon E. G. Lund U. Diczfalusy L. Lannfelt B. Winblad D. W. Russell I. Bjorkhem 2001 On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells Neurosci. Lett. 314 45 48
8. A. Papassotiropoulos D. Lutjohann M. Bagli S. Locatelli F. Jessen R. Buschfort U. Ptok I. Bjorkhem K. von Bergmann R. Heun 2002 24S- hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia J. Psychiatr. Res. 36 27 32
9. H. Kolsch D. Lutjohann M. Ludwig A. Schulte U. Ptok F. Jessen K. von Bergmann M. L. Rao W. Maier R. Heun 2002 Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease Mol. Psychiatry 7 899 902
10. A. Papassotiropoulos J. R. Streffer M. Tsolaki S. Schmid D. Thal F. Nicosia V. Iakovidou A. Maddalena D. Lutjohann E. Ghebremedhin T. Hegi T. Pasch M. Traxler A. Bruhl L. Benussi G. Binetti H. Braak R. M. Nitsch C. Hock 2003 Increased brain β-amyloid load, phosphorylated tau, and risk of Alzheimer's disease associated with an intronic CYP46 polymorphism Arch. Neurol. 60 29 35
11. A. Johansson H. Katzov H. Zetterberg L. Feuk B. Johansson N. Bogdanovic N. Andreasen B. Lenhard A. J. Brookes N. L. Pedersen K. Blennow J. A. Prince 2004 Variants of CYP46A1 may interact with age and ApoE to influence CSF Aβ42 levels in Alzheimer's disease Hum. Genet. 114 581 587
12. O. Combarros J. Infante J. Llorca J. Berciano 2004 Genetic association of CYP46 and risk for Alzheimer's disease Dement. Geriatr. Cogn. Disord. 18 257 260
13. B. Borroni S. Archetti C. Agosti N. Akkawi C. Brambilla L. Caimi C. Caltagirone M. Di Luca A. Padovani 2004 Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: From risk factors to disease modulators Neurobiol. Aging 25 47 751
14. B. Wang C. Zhang W. Zheng Z. Lu C. Zheng Z. Yang L. Wang F. Jin 2004 Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese Neurosci. Lett. 369 104 107
15. P. Desai S. T. DeKosky M. I. Kamboh 2002 Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease Neurosci. Lett. 328 9 12
16. M. Ingelsson J. Jesneck M. C. Irizarry B. T. Hyman G. W. Rebeck 2004 Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease Neurosci. Lett. 367 228 231
17. A. Kabbara N. Payet D. Cottel B. Frigard P. Amouyel J. C. Lambert 2004 Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population Neurosci. Lett. 363 139 143
18. K. A. Chalmers D. Culpan P. G. Kehoe G. K. Wilcock A. Hughes S. Love 2004 ApoE promoter, ACE1 and CYP46 polymorphisms and β-amyloid in Alzheimer's disease NeuroReport 15 95 98
19. M. P. Simons J. Keller J. Dichgans J. B. Schulz 2001 Cholesterol and Alzheimer's disease: Is there a link? Neurology 57 1089 1093
20. B. Wolozin 2003 CYP46 (24S-cholesterol hydroxylase): A genetic risk factor for Alzheimer's disease Arch. Neurol. 60 16 18
21. A. R. Koudinov E. Matsubara B. Frangione J. Ghiso 1994 The soluble form of Alzheimer's amyloid β-protein is complexed to high density lipoprotein and very high density lipoprotein in normal human plasma Biochem. Biophys. Res. Commun. 205 1164 1171
22. M. J. Ladu C. Reardon L. Van Eldik A. M. Fagan G. Bu D. M. Holtzman 2000 Lipoproteins in the central nervous system Ann. N. Y. Acad. Sci. 903 167 175
23. A. Cedazo-Minguez M. Huttinger R. F. Cowburn 2001 β-VLDL protects against Aβ(1-42) and apoE toxicity in human SH-SY5Y neuroblastoma cells NeuroReport 12 201 206
24. G. [tmp] McKhann D. Drachman M. Folstein R. Katzman D. Price 1984 Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
25. M. F. Folstein S. E. Folstein 1975 McHugh PR: Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 189 198
26. K. E. Davies 1986 Human Genetic Diseases. A Practical Approach IRL Press Oxford
27. J. Kálmán A. Juhász A. Császár A. Kanka E. Maglóczky K. Bencsik Z. Janka I. Raskó 1997 Apolipoprotein E allele frequencies in patients with late onset sporadic Alzheimer's dementia in Hungary Acta Neurol. Scand. 95 56 59
28. E. B. Wilson 1927 Probable inference, the law of succession, and statistical inference J. Am. Statist. Assoc. 22 209 212
29. D. M. Hallman E. Boerwinkle N. Saha C. Sandholzer H. J. Menzel A. Csazar G. Utermann 1991 The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations Am. J. Hum. Genet. 49 338 349
30. R. M. Harding R. R. Sokal 1988 Classification of the European language families by genetic distance Proc. Natl. Acad. Sci. USA 85 9370 9372
31. F. Panza V. Solfrizzi F. Torres F. Mastroianni A. M. Colacicco A. M. Basile C. Capurso A. D'Introno A. Del Parigi A. Capurso 2000 Apolipoprotein E in Southern Italy: Protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease Neurosci. Lett. 292 79 82
32. G. Siest P. Bertrand B. Qin B. Herbeth J. M. Serot L. Masana J. Ribalta A. P. Passmore A. Evans M. Ferrari M. Franceschi J. Shepherd M. Cuchel U. Beisiegel K. Zuchowsky A. S. Rukavina J. Sertic M. Stojanov V. Kostic A. Mitrevski V. Petrova C. Sass A. Merched J. T. Salonen L. Tiret S. Visvikis 2000 Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: The ApoEurope study. ApoEurope group Clin. Chem. Lab. Med. 38 721 730
33. M. Styczynska D. Religa A. Pfeffer E. Luczywek B. Wasiak G. Styczynski B. Peplonska T. Gabryelewicz M. Golebiowski M. Kobrys M. Barcikowska 2003 Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease Neurosci. Lett. 344 99 102
34. W. J. [tmp] McConathy A. G. Lackó J. Kálmán 1997 Senile dementia and apolipoprotein E4 Dementia 8 258
35. J. Kálmán A. Juhász Á. Rimanóczy A. Palotás M. Palotás Z. Szabó K. Boda J. Márki-Zay Z. Janka 2003 Lack of influence of the apolipoprotein E genotype on the outcome of selegiline treatment in Alzheimer's disease Dement. Geriatr. Cogn. Disord. 16 31 34